← Back to Search

NMDA Receptor Antagonist

Ketamine for Healthy Subjects

Phase < 1
Waitlist Available
Led By Marco Cecchi, PhD
Research Sponsored by ERP Biomarker Qualification Consortium
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention/dosing
Awards & highlights

Study Summary

This trial will study the effects of ketamine on healthy volunteers using an auditory test. The primary objectives are to quantify the effect size of ketamine on the test and to quantify the variability of ketamine's effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention/dosing
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention/dosing for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Correlation between Ketamine blood concentration and Ketamine-induced change in Evoked Power from the auditory steady-state response (ASSR) paradigm.
Correlation between Ketamine blood concentration and Ketamine-induced change in Inter-trial coherence (ITC) from the auditory steady-state response (ASSR) paradigm.
Ketamine
+19 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Arm 3Experimental Treatment1 Intervention
Visit 2: Placebo - Ketamine; Visit 3: Placebo - Ketamine; Visit 4: Placebo - Placebo
Group II: Arm 2Experimental Treatment1 Intervention
Visit 2: Placebo - Ketamine; Visit 3: Placebo - Placebo; Visit 4: Placebo - Ketamine
Group III: Arm 1Experimental Treatment1 Intervention
Visit 2: Placebo - Placebo; Visit 3: Placebo - Ketamine; Visit 4: Placebo - Ketamine
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ketamine
2011
Completed Phase 4
~1090

Find a Location

Who is running the clinical trial?

ERP Biomarker Qualification ConsortiumLead Sponsor
1 Previous Clinical Trials
161 Total Patients Enrolled
Alkermes, Inc.Industry Sponsor
114 Previous Clinical Trials
26,855 Total Patients Enrolled
Anavex Life Sciences Corp.Industry Sponsor
12 Previous Clinical Trials
1,669 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any openings available for enrollees at this moment?

"Affirmative. Clinicaltrials.gov demonstrates that the research project commenced on May 26th 2022 and has recently been modified on June 1st 2022. 24 individuals can take part in this study at one site of recruitment."

Answered by AI

What is the population size for this research endeavor?

"Affirmative, the information hosted on clinicaltrials.gov confirms that this medical research is presently recruiting participants. Initially posted on May 26th 2022, it was most recently updated on June 1st 2022 and requires 24 patients from a single location for enrollment."

Answered by AI

Is this research endeavor accommodating those over the age of three-quarters of a century?

"It is mandatory that participants enrolled in this medical trial are between 21 and 40 years of age, as specified by the inclusion criteria."

Answered by AI

Is it possible for me to register as a participant in this trial?

"The parameters for eligibility in this research require that potential participants have healthy subjects (hs) and are between 21 to 40 years of age. Currently, 24 individuals will be involved in the trial."

Answered by AI

Who else is applying?

What state do they live in?
California
Texas
Other
New Jersey
How old are they?
18 - 65
What site did they apply to?
Hassman Research Institute
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Hassman Research Institute: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
2022. "Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04928703.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top